PML-N leader Hanif Abbasi's life sentence in ephedrine quota case suspended by LHC

Published April 11, 2019
The file photo shows PML-N's former MNA Hanif Abbasi. — AP/File
The file photo shows PML-N's former MNA Hanif Abbasi. — AP/File

The Lahore High Court (LHC) on Thursday suspended the life sentence handed to PML-N leader Hanif Abbasi in 2018 in the ephedrine quota case, ordering his release on bail.

A two-member bench, headed by Justice Alia Neelum, after hearing detailed arguments from both sides accepted Abbasi's plea to suspend the sentence. The court, however, declared that it would continue to hear the case.

Read more: Setback for NAB as LHC grants bail to Hamza

The ephedrine case surfaced in March 2011 when then federal minister Makhdoom Shahabuddin told the National Assembly that the government will investigate the alleged allocation of a quota for the production of 9,000kg of ephedrine to two pharmaceutical companies — Berlex Lab International and Danas Pharmaceutical Limited.

According to the rules, a company cannot be allocated a production quota of more than 500kg of the drug, a limit fixed by the International Narcotics Control Board (INCB).

The Anti-Narcotics Force (ANF) had eventually registered a case in June 2012 against nine suspects, including Abbasi.

He was found guilty of selling 500kg of ephedrine to narcotics smugglers. He had obtained the controlled chemical for his company, Gray Pharmaceutical, in 2010. However, instead of using it for medicinal purposes, Abbasi sold it on to narcotics smugglers.

A fine of Rs1 million was imposed on the PML-N leader along with the life sentence. Seven others accused were acquitted in the case. The CNS Court of Rawalpindi had sentenced Hanif Abbasi to life in prison just before the July 25 general elections.

Subsequently, the PML-N leader had filed an appeal against his conviction before the LHC Rawalpindi bench, which was taken up on Aug 16.

Later, two judges of the LHC's Rawalpindi Bench had recused themselves from hearing the PML-N leader’s appeal in the ephedrine case. The case was eventually shifted to the LHC's Lahore bench.

Opinion

Editorial

Missing in action
17 Mar, 2026

Missing in action

NOT exactly known for playing a proactive role in protecting the interests of Muslim nations and populations...
Risk to stability
Updated 17 Mar, 2026

Risk to stability

THE risks to Pakistan’s fragile economic recovery from the US-Israel war on Iran cannot be dismissed. Yet the...
Enrolment push
17 Mar, 2026

Enrolment push

THE federal government has embarked upon the welcome initiative to enrol 25,000 out-of-school children in Islamabad...
Holding the line
16 Mar, 2026

Holding the line

PAKISTAN’S long battle against polio has recently produced encouraging signs. Data from the national eradication...
Power self-reliance
Updated 16 Mar, 2026

Power self-reliance

PAKISTAN’S transition to domestic sources of electricity is a welcome development for a country that has long been...
Looking for safety
16 Mar, 2026

Looking for safety

AS the Middle East conflict enters its third week, the war’s most enduring victims are not those who wage it....